A Study of Abemaciclib in Indian Women With Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Neoplasm Metastasis
Interventions: DRUG: Abemaciclib|DRUG: Nonsteroidal Aromatase Inhibitor (NSAI)|DRUG: Fulvestrant
Sponsor: Eli Lilly and Company